Doherty Institute
Health & Medicine
Research
How gene-targeting technology is transforming STI diagnosis
A portable device built on CRISPR technology can now detect multiple STIs, including syphilis, from a single sample in under an hour
Health & Medicine
Ending the global tuberculosis epidemic
TB occurs in every part of the world and remains a major public health challenge that we can end through concerted action
Health & Medicine
Q&A
Q&A: What we do (and don’t) know about Omicron
The latest COVID-19 variant, Omicron, has sparked international travel bans, stricter quarantine and a lot of “hype” worldwide – but we still have a lot to learn about the mutation
Health & Medicine
How your blood can help understand COVID-19 vaccine responses
A new biobank will collect, process and store samples from people having their COVID-19 vaccine in order to help researchers better understand immunity to the virus
Health & Medicine
Affinity, avidity, IgM, IgG, serological surveys and ‘antibody passports’
Antibody passports could be used to identify people who are vaccinated and are COVID-19 survivors. The body’s immune response helps guide which antibodies to look for in a ‘passport’
Health & Medicine
Your protective Igs: The major focus of COVID-19 vaccines
As scientists around the world continue to work on a COVID-19 vaccine – it’s important to understand how and why they work at a cellular level
Health & Medicine
How do we close the gaps in appropriate antibiotic use?
Collaboration is key to strengthening antimicrobial stewardship across regional and remote Australia
Health & Medicine
The rise of the latest drug resistant superbug
In parts of Europe, some strains of the latest superbug are already resistant to all known antibiotics – but researchers don’t yet know how it is spreading internationally
Health & Medicine
Tuberculosis: Still a major killer
Researchers for first time show the significant burden of tuberculosis on adolescents and young adults, a group often ignored in disease control efforts
Health & Medicine
HIV: Probing for a pathway to a cure
Clinical trial suggests HIV can’t replicate in people on antiretrovirals in what is a key finding for efforts to develop a cure